CIRCADIAN TECHNOLOGIES LIMITED (CIR)
Circadian is a drug development company developing innovative, biologics-based therapies for the treatment of cancer and other serious human illnesses.On this page you will find:
|
Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options |
|
Company details Closing prices Dividends Warrants & Structured Products ASX CFDs |
Delayed share price
Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.
| Code | Last | % Chg | Bid | Offer | Open | High | Low | Vol |
|---|---|---|---|---|---|---|---|---|
| CIR | 0.245 | 0% | 0.245 | 0.260 | 0.245 | 0.250 | 0.245 | 33,112 |
ASX Find a broker tool
Helps you find an ASX broker based on your needs and where you live.
CIRCADIAN TECHNOLOGIES LIMITED details
Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.
| Issuer Code | CIR |
|---|---|
| Securities | |
| Official Listing Date | 18 April, 1991 |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences |
| Exempt Foreign? | No |
| Internet Address | http://www.circadian.com.au |
| Registered Office Address | Level 1, 10 Wallace Avenue, TOORAK, VIC, AUSTRALIA, 3142 |
| Head Office Telephone | (03) 9826 0399 |
| Head Office Fax | (03) 9824 0083 |
| Share Registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067 |
| Share Registry Telephone | 1300 787 272 |
| Directors / Senior Management |
|---|
|
Ms Dominique Fisher (Chairman, Non Exec. Director) Mr Robert Klupacs (Managing Director, CEO) Mr Don Clarke (Non Exec. Director) Ms Tina McMeckan (Non Exec. Director) Mr Steven Paul Zammit (CFO) |
| Company Secretary |
Mr Steven Paul Zammit |
|---|---|
| Principal Activities | Circadian is a drug development company developing innovative, biologics-based therapies for the treatment of cancer and other serious human illnesses. |
CIRCADIAN TECHNOLOGIES LIMITED announcements
How are company announcements published on www.asx.com.au?
| Date | Price sens. |
Headline | Pages | |
|---|---|---|---|---|
| 24/05/2013 | Open Briefing | 3 | ||
| 23/05/2013 | Change of Director's Interest Notice | 3 | ||
| 20/05/2013 | Change of Director's Interest Notice | 3 | ||
| 17/05/2013 | Progress of VGX-100 Phase 1 trial to be presented at ASCO | 2 | ||
| 09/05/2013 |
|
VEGF-C shown to have major role in (AMD) | 5 | |
| 09/05/2013 |
|
VEGF-C shown to have major role in (AMD) | 4 | |
| 08/03/2013 |
|
Circadian grants world-wide licence to Santa Cruz | 2 | |
| 27/02/2013 |
|
CIRCADIAN COMMENCES WORDWIDE MARKETING AND SALES OF REAGENTS | 3 | |
| 25/02/2013 | Open Briefing CEO on Half Year Results and Outlook | 5 | ||
| 22/02/2013 | Company Secretary Appointment/Resignation | 1 |
> search for past company announcements
Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.
Closing prices
Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.
| Date | Last | % Change | High | Low | Vol * |
|---|---|---|---|---|---|
| 24 May 2013 | 0.245 | 0% | 0.250 | 0.245 | 33,112 |
| 23 May 2013 | 0.245 | -5.77% | 0.245 | 0.245 | 1,600 |
| 22 May 2013 | 0.260 | 4% | 0.260 | 0.260 | 42,000 |
| 20 May 2013 | 0.250 | 8.7% | 0.250 | 0.240 | 75,000 |
| 17 May 2013 | 0.230 | -8% | 0.230 | 0.230 | 80,000 |
* Volume of shares shown represents only those shares traded on ASX.
CIRCADIAN TECHNOLOGIES LIMITED price history chart

Dividends
How are dividends released on www.asx.com.au?
No dividends have been found for the security CIR. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.
Exchange Traded Options
No Exchange Traded Options are available over the security CIR
Warrants & Structured Products
No warrants & Structured Products are available over the security CIR
ASX CFDs
No Contracts For Differences are available over the security CIR

